Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1187-2025

Brand Name: RayStation -Intended as a Radiation Therapy Treatment Planning System Recall

Brand Name: RayStation -Intended as a Radiation Therapy Treatment Planning System Model/Catalog Number: 9.1.0.933, 9.2.0.483, 10.0.0.1154, 10.0.1.52 and 10.0.2.10 Software Version: RayStation 9B, 9B Service Pack 1, 10A, 10A Service Pack 1 and 2

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brand Name: RayStation -Intended as a Radiation Therapy Treatment Planning System. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1187-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jan 16, 2025
FDA report date
Feb 26, 2025
Quantity in commerce
1
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Brand Name: RayStation -Intended as a Radiation Therapy Treatment Planning System Model/Catalog Number: 9.1.0.933, 9.2.0.483, 10.0.0.1154, 10.0.1.52 and 10.0.2.10 Software Version: RayStation 9B, 9B Service Pack 1, 10A, 10A Service Pack 1 and 2

Affected model & UDI checker

Search the exact identifiers published for Z-1187-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
9.1.0.933Brand Name: RayStation -Intended as a Radiation Therapy Treatment Planning SystemCheck source noticeNot specified
9.2.0.483Brand Name: RayStation -Intended as a Radiation Therapy Treatment Planning SystemCheck source noticeNot specified
10.0.0.1154Brand Name: RayStation -Intended as a Radiation Therapy Treatment Planning SystemCheck source noticeNot specified
10.0.1.52Brand Name: RayStation -Intended as a Radiation Therapy Treatment Planning SystemCheck source noticeNot specified
10.0.2.10Brand Name: RayStation -Intended as a Radiation Therapy Treatment Planning SystemCheck source noticeNot specified
Not specifiedBrand Name: RayStation -Intended as a Radiation Therapy Treatment Planning SystemCheck source notice07350002010266
FDA code information

Lot Code: UDI: 0735000201026620191220, 0735000201029720200310, 0735000201030320200526, 0735000201036520200526 and 0735000201065520220608 GTIN: 07350002010266 and 07350002010297, 07350002010303, 07350002010365 and 07350002010655 Serial Numbers: 9.1.0.933, 9.2.0.483, 10.0.0.1154, 10.0.1.52 and 10.0.2.10 Software Revisions: RayStation 9B, 9B Service Pack 1, 10A, 10A Service Pack 1 and 2 Expiration Date: 2025-06-16

View the original FDA recall notice

Why was this product recalled?

Inconsistency in the use of Density uncertainty in the RayStation functions Robust optimization, Robust evaluation and Compute perturbed dose for proton and light ion treatment plans when a HU-to-mass density CT calibration curve used in RayStation version 4.5 to 2024B including some service packs.

What actions did RAYSEARCH LABORATORIES AB take?

Raysearch issued Field Safety Notice, Medical Device Correction #148655 RayStation version 4.5 to 2024B including some service packs via email on 1/17/25. Letter states reason for recall, health risk and action to take: For users of HU-to-mass density CT calibration curves If a user wants to evaluate a plan with respect to relative stopping power/WE range error rather than mass density errors, there are two options: Option 1. Use a HU-to-SPR CT calibration curve instead of a HU-to-mass density curve. " For evaluation of an existing case, the evaluation can be done on an anonymized and exported copy of the patient and plan. " Contact RaySearch Service if you need help with the creation of a HU-to-SPR curve from an existing HU-to-mass density curve. Option 2. Evaluate the plan using a higher (effective) mass density uncertainty that gives similar relative stopping power and WE range change as the nominal value. " The following values of Effective mass density errors that give similar result as an intended Stopping power error have been deduced from a limited set of patients: " For other values of intended Stopping power error, interpolate the approximate Effective mass density value from the table above. " The values are estimates based on a few patients and are expected to vary slightly depending on the mass densities along the beam path. " Note that the values are not symmetrical around 0. For users of HU-to-SPR CT calibration curves Be aware that the density uncertainty given in Robust evaluation, Compute perturbed dose and Robust optimization is used directly to scale stopping power and therefore WE range. Starting from RayStation v2025, scheduled for market release in April 2025 (subject to market clearance in some markets), the impact of the mass density uncertainty in Robust evaluation and Compute perturbed dose when using a HU-to-mass density CT calibration curve will be changed to harmonize with the other use cases. This means that as of RayStat

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology